Louis Moore Bacon's LLY Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 11,000 shares of Eli Lilly and Company (LLY) worth $11.82 M, representing 0.17% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in LLY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2019, adding 83,162 shares. Largest reduction occurred in Q4 2022, reducing 89,980 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +11,000 | New Buy | 11,000 | $1074.68 |
| Q3 2025 | -24,000 | Sold Out | 0 | $0.00 |
| Q2 2025 | +24,000 | New Buy | 24,000 | $779.53 |
| Q3 2024 | -21,000 | Sold Out | 0 | $0.00 |
| Q2 2024 | -8,000 | Reduce 27.59% | 21,000 | $905.38 |
| Q1 2024 | -25,000 | Reduce 46.30% | 29,000 | $777.96 |
| Q4 2023 | +54,000 | New Buy | 54,000 | $582.92 |
| Q3 2023 | -22,200 | Sold Out | 0 | $0.00 |
| Q2 2023 | +22,200 | New Buy | 22,200 | $468.98 |
| Q4 2022 | -89,980 | Sold Out | 0 | $0.00 |
| Q3 2022 | +9,680 | Add 12.05% | 89,980 | $323.35 |
| Q2 2022 | +80,300 | New Buy | 80,300 | $324.23 |
| Q3 2021 | -33,545 | Sold Out | 0 | $0.00 |
| Q2 2021 | +33,545 | New Buy | 33,545 | $229.51 |
| Q1 2020 | -83,162 | Sold Out | 0 | $0.00 |
| Q4 2019 | +83,162 | New Buy | 83,162 | $131.43 |
| Q3 2019 | -63,176 | Sold Out | 0 | $0.00 |
| Q2 2019 | -17,729 | Reduce 21.91% | 63,176 | $110.79 |
| Q1 2019 | +34,546 | Add 74.52% | 80,905 | $129.76 |
| Q4 2018 | +46,359 | New Buy | 46,359 | $115.73 |
| Q2 2016 | -50,000 | Sold Out | 0 | $0.00 |
| Q1 2016 | +50,000 | New Buy | 50,000 | $72.02 |
Louis Moore Bacon's Eli Lilly and Company Investment FAQs
Louis Moore Bacon first purchased Eli Lilly and Company (LLY) in Q1 2016, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Eli Lilly and Company (LLY) for 22 quarters since Q1 2016.
Louis Moore Bacon's largest addition to Eli Lilly and Company (LLY) was in Q4 2019, adding 83,162 shares worth $10.93 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 11,000 shares of Eli Lilly and Company (LLY), valued at approximately $11.82 M.
As of the Q4 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.17% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Eli Lilly and Company (LLY) was 89,980 shares, as reported at the end of Q3 2022.